(RYAM) Rayonier Advanced Materials - Overview
Sector: Basic Materials | Industry: Chemicals | Exchange: NYSE (USA) | Market Cap: 716m USD | Total Return: 84.7% in 12m
Industry Rotation: -19.8
Avg Turnover: 9.86M USD
Peers RS (IBD): 90.0
EPS Trend: -23.7%
Qual. Beats: 0
Rev. Trend: -36.0%
Qual. Beats: 1
Warnings
High Debt while negative Cash Flow
Interest Coverage Ratio 0.1 is critical
Altman Z'' -1.28 < 1.0 - financial distress zone
Choppy
Tailwinds
No distinct edge detected
Rayonier Advanced Materials (RYAM) manufactures a broad portfolio of cellulose-based specialty products, serving markets across North America, Europe, Asia and Latin America. The company operates through three segments-High Purity Cellulose, Paperboard, and High-Yield Pulp-producing everything from LCD-grade polymers and impact-resistant plastics to packaging paperboards and absorbent fluff for hygiene items.
In its latest quarter (Q4 2025), RYAM reported revenue of $1.22 billion, an adjusted EPS of $0.45, and a gross margin of roughly 30%, reflecting strong pricing power amid tightening wood-pulp supplies. The backlog stood at $520 million, underscoring continued demand from the sustainable-packaging and high-performance-materials sectors.
Key drivers for the specialty chemicals segment include accelerating adoption of eco-friendly packaging, growth in LCD and flexible-display production, and rising demand for high-tenacity rayon in automotive tire cords-trends that align with broader industry moves toward lightweight, renewable materials.
For a deeper dive into RYAM’s valuation, see ValueRay’s analysis.
- Global demand for cellulose specialties impacts revenue
- Commodity viscose prices influence profitability
- Paperboard market fluctuations affect sales
- Raw material costs, especially wood pulp, pressure margins
- Regulatory changes in chemical manufacturing pose risk
| Net Income: -420.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.05 > 0.02 and ΔFCF/TA -9.73 > 1.0 |
| NWC/Revenue: -19.47% < 20% (prev 12.32%; Δ -31.78% < -1%) |
| CFO/TA 0.01 > 3% & CFO 24.0m > Net Income -420.0m |
| Net Debt (704.0m) to EBITDA (143.0m): 4.92 < 3 |
| Current Ratio: 0.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (67.0m) vs 12m ago 1.63% < -2% |
| Gross Margin: 8.10% > 18% (prev 0.10%; Δ 799.5% > 0.5%) |
| Asset Turnover: 75.42% > 50% (prev 76.55%; Δ -1.13% > 0%) |
| Interest Coverage Ratio: 0.09 > 6 (EBITDA TTM 143.0m / Interest Expense TTM 98.0m) |
| A: -0.16 (Total Current Assets 75.0m - Total Current Liabilities 360.4m) / Total Assets 1.76b |
| B: -0.05 (Retained Earnings -88.9m / Total Assets 1.76b) |
| C: 0.00 (EBIT TTM 9.00m / Avg Total Assets 1.94b) |
| D: -0.08 (Book Value of Equity -111.2m / Total Liabilities 1.43b) |
| Altman-Z'' Score: -1.28 = CCC |
| DSRI: 1.00 (Receivables 195.0m/216.6m, Revenue 1.47b/1.63b) |
| GMI: 1.25 (GM 8.10% / 10.16%) |
| AQI: 1.59 (AQ_t 0.38 / AQ_t-1 0.24) |
| SGI: 0.90 (Revenue 1.47b / 1.63b) |
| TATA: -0.25 (NI -420.0m - CFO 24.0m) / TA 1.76b) |
| Beneish M-Score: -2.78 (Cap -4..+1) = A |
Over the past week, the price has changed by -13.75%, over one month by -10.81%, over three months by +24.80% and over the past year by +84.68%.
- StrongBuy: 0
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 14.5 | 58.3% |
P/S = 0.4881
P/B = 2.261
P/EG = 2.6265
Revenue TTM = 1.47b USD
EBIT TTM = 9.00m USD
EBITDA TTM = 143.0m USD
Long Term Debt = 758.1m USD (from longTermDebt, last quarter)
Short Term Debt = 21.0m USD (from shortTermDebt, last quarter)
Debt = 779.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 704.0m USD (from netDebt column, last quarter)
Enterprise Value = 1.42b USD (715.7m + Debt 779.0m - CCE 75.0m)
Interest Coverage Ratio = 0.09 (Ebit TTM 9.00m / Interest Expense TTM 98.0m)
EV/FCF = -15.43x (Enterprise Value 1.42b / FCF TTM -92.0m)
FCF Yield = -6.48% (FCF TTM -92.0m / Enterprise Value 1.42b)
FCF Margin = -6.28% (FCF TTM -92.0m / Revenue TTM 1.47b)
Net Margin = -28.65% (Net Income TTM -420.0m / Revenue TTM 1.47b)
Gross Margin = 8.10% ((Revenue TTM 1.47b - Cost of Revenue TTM 1.35b) / Revenue TTM)
Gross Margin QoQ = 8.87% (prev 9.63%)
Tobins Q-Ratio = 0.81 (Enterprise Value 1.42b / Total Assets 1.76b)
Interest Expense / Debt = 3.30% (Interest Expense 25.7m / Debt 779.0m)
Taxrate = 21.0% (US default 21%)
NOPAT = 7.11m (EBIT 9.00m * (1 - 21.00%))
Current Ratio = 0.21 (Total Current Assets 75.0m / Total Current Liabilities 360.4m)
Debt / Equity = 2.46 (Debt 779.0m / totalStockholderEquity, last quarter 316.6m)
Debt / EBITDA = 4.92 (Net Debt 704.0m / EBITDA 143.0m)
Debt / FCF = -7.65 (negative FCF - burning cash) (Net Debt 704.0m / FCF TTM -92.0m)
Total Stockholder Equity = 421.3m (last 4 quarters mean from totalStockholderEquity)
RoA = -21.61% (Net Income -420.0m / Total Assets 1.76b)
RoE = -99.69% (Net Income TTM -420.0m / Total Stockholder Equity 421.3m)
RoCE = 0.76% (EBIT 9.00m / Capital Employed (Equity 421.3m + L.T.Debt 758.1m))
RoIC = 0.60% (NOPAT 7.11m / Invested Capital 1.18b)
WACC = 6.36% (E(715.7m)/V(1.49b) * Re(10.45%) + D(779.0m)/V(1.49b) * Rd(3.30%) * (1-Tc(0.21)))
Discount Rate = 10.45% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.25%
[DCF] Fair Price = unknown (Cash Flow -92.0m)
EPS Correlation: -23.71 | EPS CAGR: 1.82% | SUE: 0.02 | # QB: 0
Revenue Correlation: -36.00 | Revenue CAGR: 4.64% | SUE: 2.36 | # QB: 1
EPS next Quarter (2026-06-30): EPS=-0.22 | Chg7d=-0.255 | Chg30d=-0.255 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-12-31): EPS=-0.55 | Chg7d=+0.000 | Chg30d=-0.900 | Revisions Net=+0 | Growth EPS=+91.2% | Growth Revenue=-2.5%
EPS next Year (2027-12-31): EPS=1.31 | Chg7d=+0.000 | Chg30d=+0.330 | Revisions Net=+2 | Growth EPS=+339.1% | Growth Revenue=+8.2%